EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial)

医学 四分位间距 内镜逆行胰胆管造影术 随机对照试验 支架 不利影响 外科 内镜超声 内科学 胰腺炎
作者
Anthony Yuen Bun Teoh,Betrand Napoleon,Rastislav Kunda,Paolo Giorgio Arcidiacono,Pradermchai Kongkam,Alberto Larghi,Van der Merwe,Jeremies Jacques,Romain Legros,Ratanachu-Ek Thawee,Payal Saxena,Maridi Aerts,Lívia Archibugi,Shannon M. Chan,Fabien Fumex,Arthur J. Kaffes,Mark Tsz Wah,Nouredin Messaoudi,Gianenrico Rizzatti,Kelvin K. Ng
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:165 (2): 473-482.e2 被引量:90
标识
DOI:10.1053/j.gastro.2023.04.016
摘要

Background & AimsSeveral studies have compared primary endoscopic ultrasound (EUS)-guided biliary drainage to endoscopic retrograde cholangiopancreatography (ERCP) with insertion of metal stents in unresectable malignant distal biliary obstruction (MDBO) and the results were conflicting. The aim of the current study was to compare the outcomes of the procedures in a large-scale study.MethodsThis was a multicenter international randomized controlled study. Consecutive patients admitted for obstructive jaundice due to unresectable MDBO were recruited. Patients were randomly allocated to receive EUS-guided choledocho-duodenostomy (ECDS) or ERCP for drainage. The primary outcome was the 1-year stent patency rate. Other outcomes included technical success, clinical success, adverse events, time to stent dysfunction, reintervention rates, and overall survival.ResultsBetween January 2017 and February 2021, 155 patients were recruited (ECDS 79, ERCP 76). There were no significant differences in 1-year stent patency rates (ECDS 91.1% vs ERCP 88.1%, P = .52). The ECDS group had significantly higher technical success (ECDS 96.2% vs ERCP 76.3%, P < .001), whereas clinical success was similar (ECDS 93.7% vs ERCP 90.8%, P = .559). The median (interquartile range) procedural time was significantly shorter in the ECDS group (ECDS 10 [5.75–18] vs ERCP 25 [14–40] minutes, P < .001). The rate of 30-day adverse events (P = 1) and 30-day mortality (P = .53) were similar.ConclusionBoth procedures could be options for primary biliary drainage in unresectable MDBO. ECDS was associated with higher technical success and shorter procedural time then ERCP. Primary ECDS may be preferred when difficult ERCPs are anticipated. This study was registered to Clinicaltrials.gov NCT03000855. Several studies have compared primary endoscopic ultrasound (EUS)-guided biliary drainage to endoscopic retrograde cholangiopancreatography (ERCP) with insertion of metal stents in unresectable malignant distal biliary obstruction (MDBO) and the results were conflicting. The aim of the current study was to compare the outcomes of the procedures in a large-scale study. This was a multicenter international randomized controlled study. Consecutive patients admitted for obstructive jaundice due to unresectable MDBO were recruited. Patients were randomly allocated to receive EUS-guided choledocho-duodenostomy (ECDS) or ERCP for drainage. The primary outcome was the 1-year stent patency rate. Other outcomes included technical success, clinical success, adverse events, time to stent dysfunction, reintervention rates, and overall survival. Between January 2017 and February 2021, 155 patients were recruited (ECDS 79, ERCP 76). There were no significant differences in 1-year stent patency rates (ECDS 91.1% vs ERCP 88.1%, P = .52). The ECDS group had significantly higher technical success (ECDS 96.2% vs ERCP 76.3%, P < .001), whereas clinical success was similar (ECDS 93.7% vs ERCP 90.8%, P = .559). The median (interquartile range) procedural time was significantly shorter in the ECDS group (ECDS 10 [5.75–18] vs ERCP 25 [14–40] minutes, P < .001). The rate of 30-day adverse events (P = 1) and 30-day mortality (P = .53) were similar. Both procedures could be options for primary biliary drainage in unresectable MDBO. ECDS was associated with higher technical success and shorter procedural time then ERCP. Primary ECDS may be preferred when difficult ERCPs are anticipated. This study was registered to Clinicaltrials.gov NCT03000855.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小蘑菇应助无奈秋荷采纳,获得10
1秒前
到处找帮手的刘完成签到,获得积分10
2秒前
2秒前
NexusExplorer应助俏皮的白柏采纳,获得10
4秒前
4秒前
科目三应助药毛儿采纳,获得10
6秒前
egg发布了新的文献求助10
6秒前
lyting完成签到,获得积分10
6秒前
阿萨德完成签到,获得积分10
6秒前
万能图书馆应助多多采纳,获得10
7秒前
风起完成签到 ,获得积分10
7秒前
wwwwww完成签到,获得积分10
7秒前
量子星尘发布了新的文献求助10
8秒前
无花果应助好好采纳,获得10
8秒前
8秒前
xyx945应助创新采纳,获得10
10秒前
11秒前
12秒前
情怀应助madefu采纳,获得10
13秒前
whatever应助arrebol采纳,获得10
14秒前
秦羽发布了新的文献求助10
14秒前
专注的乐荷完成签到,获得积分20
14秒前
超级飞侠应助YYYZZX1采纳,获得10
15秒前
16秒前
17秒前
Yanz完成签到,获得积分10
18秒前
18秒前
19秒前
善良的非笑完成签到,获得积分10
21秒前
21秒前
小二郎应助jiabaoyu采纳,获得10
21秒前
无奈秋荷发布了新的文献求助10
22秒前
23秒前
黄哈哈发布了新的文献求助10
24秒前
多多发布了新的文献求助10
24秒前
26秒前
李健的小迷弟应助Brian采纳,获得10
26秒前
26秒前
26秒前
liujian完成签到,获得积分10
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988827
求助须知:如何正确求助?哪些是违规求助? 3531197
关于积分的说明 11252739
捐赠科研通 3269830
什么是DOI,文献DOI怎么找? 1804815
邀请新用户注册赠送积分活动 881915
科研通“疑难数据库(出版商)”最低求助积分说明 809028